Femia AN - Search Results

Year	Number of Results
2010	1
2013	4
2014	3
2015	1
2016	8
2017	7
2018	4
2019	6
2020	9
2021	6
2023	5
2024	6

1

Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment.

Mazori DR, Femia AN, Vleugels RA. Mazori DR, et al. Among authors: femia an. Curr Rheumatol Rep. 2017 Nov 4;19(12):74. doi: 10.1007/s11926-017-0700-6. Curr Rheumatol Rep. 2017. PMID: 29101481 Review.

2

Clinical Characteristics of Lupus Erythematosus Panniculitis/Profundus: A Retrospective Review of 61 Patients.

Rangel LK, Villa-Ruiz C, Lo K, Cobos G, Lo Sicco K, Vleugels RA, Femia AN. Rangel LK, et al. Among authors: femia an. JAMA Dermatol. 2020 Nov 1;156(11):1264-1266. doi: 10.1001/jamadermatol.2020.2797. JAMA Dermatol. 2020. PMID: 32876656 Free PMC article.

3

Raynaud's phenomenon: Current concepts.

Stringer T, Femia AN. Stringer T, et al. Among authors: femia an. Clin Dermatol. 2018 Jul-Aug;36(4):498-507. doi: 10.1016/j.clindermatol.2018.04.007. Epub 2018 Apr 10. Clin Dermatol. 2018. PMID: 30047433 Review.

4

Generalized essential telangiectasia.

Wiznia LE, Steuer AB, Penn LA, Meehan SA, Femia AN. Wiznia LE, et al. Among authors: femia an. Dermatol Online J. 2018 Dec 15;24(12):13030/qt2926z3f5. Dermatol Online J. 2018. PMID: 30677795 Free article.

5

Cutaneous dermatomyositis: an updated review of treatment options and internal associations.

Femia AN, Vleugels RA, Callen JP. Femia AN, et al. Am J Clin Dermatol. 2013 Aug;14(4):291-313. doi: 10.1007/s40257-013-0028-6. Am J Clin Dermatol. 2013. PMID: 23754636 Review.

6

Covert clues: the non-hallmark cutaneous manifestations of dermatomyositis.

Castillo RL, Femia AN. Castillo RL, et al. Among authors: femia an. Ann Transl Med. 2021 Mar;9(5):436. doi: 10.21037/atm-20-5252. Ann Transl Med. 2021. PMID: 33842657 Free PMC article. Review.

7

Tofacitinib Citrate for Refractory Cutaneous Dermatomyositis: An Alternative Treatment.

Kurtzman DJ, Wright NA, Lin J, Femia AN, Merola JF, Patel M, Vleugels RA. Kurtzman DJ, et al. Among authors: femia an. JAMA Dermatol. 2016 Aug 1;152(8):944-5. doi: 10.1001/jamadermatol.2016.0866. JAMA Dermatol. 2016. PMID: 27120749 No abstract available.

8

Cardiovascular Risk Management in Patients Treated with JAK Inhibitors.

Shah JT, Shah KT, Femia AN, Lo Sicco KI, Merola JF, Weber B, Garshick MS. Shah JT, et al. Among authors: femia an. J Cardiovasc Pharmacol. 2023 Aug 10:10.1097/FJC.0000000000001470. doi: 10.1097/FJC.0000000000001470. Online ahead of print. J Cardiovasc Pharmacol. 2023. PMID: 37566808

9

Polishing the crystal ball: mining multi-omics data in dermatomyositis.

Castillo RL, Femia AN. Castillo RL, et al. Among authors: femia an. Ann Transl Med. 2021 Mar;9(5):435. doi: 10.21037/atm-20-5319. Ann Transl Med. 2021. PMID: 33842656 Free PMC article. Review.

10

Utility of magnetic resonance imaging in the diagnosis of eosinophilic fasciitis: A multicenter retrospective cohort study.

Shahriari N, Mazori DR, Shahriari M, Taylor D, Shaw K, LaChance AH, Femia AN, Vleugels RA. Shahriari N, et al. Among authors: femia an. J Am Acad Dermatol. 2023 Dec;89(6):1313-1315. doi: 10.1016/j.jaad.2023.08.063. Epub 2023 Sep 1. J Am Acad Dermatol. 2023. PMID: 37659455 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

52 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year